Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Delayed Response to Pharmacy Recommendations for Medication Regimen Reviews

Mayfield Heights, Ohio Survey Completed on 05-29-2025

Penalty

Fine: $173,90029 days payment denial
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to address pharmacy recommendations in a timely manner for two residents reviewed for unnecessary medications. For one resident with multiple diagnoses including anxiety and depression, the pharmacist recommended a trial discontinuation of Xanax while titrating buspirone upward. Although the prescriber indicated agreement, there was no identifiable signature or date, and the recommendation was not addressed in a timely manner, with the medication only discontinued several months later. Nurses' notes did not mention the pharmacy recommendations during this period, and facility leadership confirmed the delay in addressing the pharmacist's input. For another resident with epilepsy and a history of encephalitis, the pharmacist recommended adjusting the administration schedule of Trazodone and monitoring for adverse effects, but the physician did not respond to the recommendation, and the medication was eventually discontinued by a hospital physician. Additionally, the pharmacist recommended clarifying the duration and monitoring requirements for Enoxaparin, but the physician did not respond until approximately two months later. Facility policy required monthly medication regimen reviews and timely physician responses to pharmacist recommendations, which were not followed in these cases.

An unhandled error has occurred. Reload 🗙